iiinova — where your digital self keeps evolving

Bert Power

@bertp68.bsky.social

618 followers 500 following 5 posts

Nephrologist, Bristol UK. Enjoying clinical practice, dialysis research & national policy improvement in kidney care. Focus on stroke & CV disease. All views represent personal opinion only

Posts Replies Media

Bert Power @bertp68.bsky.social · 05/06/2026

Yup. No news with this one

Reposted by Bert Power

Kidney Care UK @kidneycareuk.bsky.social · 12/03/2026

World Kidney Day 2026 is here! Share this post to spread the word to your followers. What are you doing to support #WorldKidneyDay this year? Share why it's important to you 💛 #KidneysMatter

A bright yellow image with bold black text stating, "I'm supporting World Kidney Day." Behind the copy is the shadow of a kidney. A hashtag at the bottom reads "#KidneysMatter."

Bert Power @bertp68.bsky.social · 06/09/2025

This disease is on the rise – and many people don’t know that they have it - National Geographic

Bert Power @bertp68.bsky.social · 25/02/2025

It’s a way of getting my SBP >200 mmHg

000

Reposted by Bert Power

Prof Claire Hills @chillslincoln79.bsky.social · 12/12/2024

Europe allows Novo to include reduction of kidney disease in Ozempic label 👩‍🔬🧪🥼 #kidneydisease #NephSky #diabetes #weightloss #GLP-1 #Semaglutide #Ozempic #CardioSky #cardiorenal 👇👇👇 www.reuters.com/business/hea...

Europe allows Novo to include reduction of kidney disease in Ozempic label

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the label of its diabetes drug Ozempic, the Danish drugmaker said in a statement on Thursday.

Bert Power @bertp68.bsky.social · 26/11/2024

What options have you got in the US ? The GSK move appears commercial. In UK, Roxy for non-dialysis with vadadustat pitching for dialysis.

Bert Power @bertp68.bsky.social · 16/11/2024

The never-ending bane of HF / CKD meds management. Admission leads to omission.